The latest news from British Patient Capital
Press release 04 November 2024
British Patient Capital – Full Year Results for the period ending 31 March 2024
Driving long-term growth: British Patient Capital’s total fund and co-investment commitments reach £2.3 billion, retaining its position as the UK’s largest domestic investor in venture and venture growth capital. Total assets under management have now reached £3.125 billion.
Filter Close filters
Displaying 71 - 80 of 95 results
Filter news
Showing 71 - 80 of 95 results
-
British Patient Capital Invests in Quantexa’s Series D funding roundPress release
13 July 2021 -
British Patient Capital Launches Life Sciences Investment ProgrammePress release
07 July 2021 -
British Patient Capital Announces $75m Commitment to $680m Balderton Capital Growth fundPress release
10 June 2021 -
British Patient Capital Announces Cornerstone Commitment to £110m Amadeus V Technology FundPress release
30 April 2021 -
British Patient Capital Announces Commitment to Abingworth’s latest fund - British Patient CapitalPress release
18 February 2021 -
British Patient Capital Announces Cornerstone Commitment to Advent Life Sciences’ third fundPress release
18 February 2021 -
British Patient Capital Commits £15m to Seedcamp’s fifth fund - British Patient CapitalPress release
11 November 2020 -
British Patient Capital – Full Year Results for the period ending 31 March 2020 - British Patient CapitalPress release
02 November 2020 -
British Patient Capital Commits $35m to Evolution Equity Partners to Invest in Growth Stage Cybersecurity CompaniesPress release
23 October 2020 -
British Patient Capital commits £20m to Kindred Capital’s second fundPress release
21 September 2020